ALS Drug Shows Promise for Alzheimer’s in Animal Study

ALS Drug Shows Promise for Alzheimer's in Animal Study

Source: Mirage News

Experimental drug NU-9 — a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of

Experimental drug NU-9 — a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) — improves neuron health in animal models of Alzheimer's disease, … [6834 chars]

Read more